Russell Investments Group’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-20,566
| Closed | -$58.8K | – | 3820 |
|
|
2024
Q3 | $58.8K | Sell |
20,566
-18,175
| -47% | -$52K | ﹤0.01% | 2759 |
|
|
2024
Q2 | $113K | Buy |
38,741
+4,238
| +12% | +$12.4K | ﹤0.01% | 2602 |
|
|
2024
Q1 | $110K | Buy |
+34,503
| New | +$110K | ﹤0.01% | 2563 |
|
|
2022
Q3 | – | Sell |
-8,421
| Closed | -$21K | – | 2991 |
|
|
2022
Q2 | $21K | Sell |
8,421
-986
| -10% | -$2.46K | ﹤0.01% | 2797 |
|
|
2022
Q1 | $42K | Sell |
9,407
-18,771
| -67% | -$83.8K | ﹤0.01% | 2638 |
|
|
2021
Q4 | $191K | Sell |
28,178
-9,484
| -25% | -$64.3K | ﹤0.01% | 2725 |
|
|
2021
Q3 | $274K | Sell |
37,662
-1,465
| -4% | -$10.7K | ﹤0.01% | 2678 |
|
|
2021
Q2 | $391K | Buy |
39,127
+23,939
| +158% | +$239K | ﹤0.01% | 2695 |
|
|
2021
Q1 | $144K | Buy |
+15,188
| New | +$144K | ﹤0.01% | 2907 |
|